作者: Sanne E. Hoeks , Lisanne Schenkeveld , Peter P.T. de Jaegere , Jeroen J. Bax , Ron T. van Domburg
DOI: 10.1016/J.AMJCARD.2009.06.038
关键词:
摘要: The current guidelines have recommended postponing noncardiac surgery (NCS) for ≥6 weeks after bare metal stent (BMS) placement and ≥1 year drug-eluting (DES) placement. However, much debate has ensued about these intervals. aim of the present study was to assess influence different intervals between stenting NCS use dual antiplatelet therapy on occurrence perioperative major adverse cardiac events (MACEs). We identified 550 patients (376 with a DES 174 BMS) by cross-matching Erasmus Medical Center percutaneous coronary intervention (PCI) database database. following PCI-BMS ( 3 months) or PCI-DES 12 were studied. MACEs included death, myocardial infarction, repeated revascularization. In group, rate during months 50%, 14%, 4%, respectively (overall p months, respectively, overall